Skip to main content

Table 3 Hazard ratios of diabetes incidence comparing individual angiotensin receptor blocker with losartan

From: Different angiotensin receptor blockers and incidence of diabetes: a nationwide population-based cohort study

  Valsartan Irbesartan Candesartan Telmisartan Olmesartan
All subjects
Crude 0.99 (0.97-1.01) 0.95 (0.93-0.97) 1.13 (1.09-1.17) 0.98 (0.95-1.01) 1.35 (1.29-1.40)
Multivariable regression analysis 1.01 (0.99-1.03) 0.99 (0.97-1.02) 0.99 (0.96-1.03) 0.99 (0.96-1.03) 1.07 (1.03-1.12)
Multivariable regression adjusted for mean daily dosage 1.01 (0.99-1.03) 0.99 (0.97-1.01) 0.99 (0.96-1.02) 0.99 (0.96-1.02) 1.07 (1.03-1.12)
Excluding those followed for less than one year
Crude 1.00 (0.98-1.02) 0.97 (0.94-0.99) 1.18 (1.14-1.23) 1.00 (0.96-1.03) 1.48 (1.41-1.55)
Multivariable regression analysis 1.02 (1.00-1.04) 1.01 (0.98-1.03) 1.00 (0.96-1.04) 1.00 (0.96-1.03) 1.09 (1.04-1.14)
Multivariable regression adjusted for mean daily dosage 1.02 (1.00-1.04) 1.00 (0.98-1.03) 0.99 (0.96-1.03) 1.00 (0.96-1.03) 1.09 (1.05-1.14)
  1. Multivariable regression analysis: adjusted for baseline covariates by traditional multivariable regression with stepwise variable selection.